Umit Tapan1, J Bruno Pestana, John C Lee, Adam Lerner. Show Affiliations » 1. Section of Hematology and Oncology, Evans Department of Medicine, Boston University School of Medicine , Boston, MA , USA.
Abstract
Entities: Disease Species
Mesh： See more » Antigens, CD20/metabolismAntineoplastic Combined Chemotherapy Protocols/therapeutic useCyclophosphamide/administration & dosageEpstein-Barr Virus Infections/etiologyEpstein-Barr Virus Infections/metabolismEpstein-Barr Virus Infections/virologyEpstein-Barr Virus Nuclear Antigens/metabolismEtoposide/administration & dosageFatal OutcomeHeart Atria/pathologyHeart Neoplasms/complicationsHeart Neoplasms/drug therapyHerpesvirus 4, Human/isolation & purificationHerpesvirus 4, Human/metabolismHerpesvirus 4, Human/physiologyHost-Pathogen InteractionsHumansImmunohistochemistryInterferon Regulatory Factors/metabolismLymphoma, Large B-Cell, Diffuse/drug therapyLymphoma, Large B-Cell, Diffuse/etiologyLymphoma, Large B-Cell, Diffuse/virologyMaleMiddle AgedMyxoma/complicationsMyxoma/drug therapyPrednisone/administration & dosageRituximab/administration & dosageVincristine/administration & dosageViral Proteins/metabolism
Substances： See more » Antigens, CD20EBNA-2 protein, Human herpesvirus 4Epstein-Barr Virus Nuclear AntigensInterferon Regulatory FactorsViral Proteinsinterferon regulatory factor-4RituximabVincristineEtoposideCyclophosphamidePrednisone
Year: 2014 PMID： 24794809 DOI： 10.3109/10428194.2014.919632
Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022